肝素:在疟疾和高血压的界面上是一个缺失的环节
Hari Shankar1,2, Auley De3,4, Anat Florentin1
1The Kuvin Center for the Study of Infectious and Tropical Diseases, & Department of Microbiology and Molecular Genetics, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
IJID regions
|January 31, 2025
概括
暴露于疟疾可能会通过通过荷尔蒙肝素改变铁代谢增加高血压风险. 这表明这些疾病在疟疾流行地区之间存在潜在的遗传联系.
科学领域:
- 全球卫生健康 全球卫生健康
- 传染性疾病是传染性疾病.
- 非传染性疾病非传染性疾病
背景情况:
- 疟疾和高血压在全球南部普遍存在.
- 目前正在调查这些疾病之间的潜在联系.
- 遗传因素可能在疟疾流行地区的高血压发展中发挥作用.
研究的目的:
- 探索疟疾和高血压之间的联系.
- 为了研究肝素在疟疾引起的高血压发展中的作用.
- 检查疟疾对铁代谢和高血压的影响.
主要方法:
- 对新出现的关于遗传选择压力的证据的审查.
- 分析肝素在疟疾相关高血压中的作用.
- 调查疟疾暴露后铁代谢变化的研究.
主要成果:
- 新出现的证据表明,在疟疾流行地区,高血压的遗传选择.
- 肝激素赫普西丁 (Hepcidin) 在疟疾后显著影响高血压的发展.
- 疟疾暴露通过调节肝素改变铁代谢,导致铁缺乏和高血压.
结论:
- 疟疾可能通过改变铁代谢和肝素调节导致高血压的发展.
- 需要进一步的研究才能充分理解疟疾,铁,肝素和高血压之间的复杂关系.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
131
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
131
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Antihypertensive Drugs: Potassium-Sparing Diuretics
441
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
441
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
127
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
127
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
131
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
131
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
398
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
398


